Source: Eur Respir J, 55 (2) 2000048; 10.1183/13993003.00048-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Duncan Keeley, Jane E. Scullion, Omar S. Usmani. Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers. Eur Respir J, 55 (2) 2000048; 10.1183/13993003.00048-2020

Member's Comments

No comment yet.

Related content which might interest you: Minimising the environmental impact of inhaled therapies Source: Eur Respir J, 55 (5) 2000721; 10.1183/13993003.00721-2020 Year: 2020 Modelling the beneficial impact of inhaled corticosteroids on health outcomes among COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004 Opinions on the environmental impact of inhaler devices in UK respiratory care Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 The use of pressurized metered-dose inhalers mith spacer in the treatment of asthmatic crises: impacts on treatment costs Source: Eur Respir J 2006; 28: Suppl. 50, 710s Year: 2006 Assessment of the technique in different inhalation devices and investigating the factors associated with inhaler misuse in COPD patients Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017 Pros: governments should impose targets for healthcare professionals to switch their respiratory disease patients to inhalers with a low global warming potential Source: International Congress 2019 – Recent clinical advances in inhalation therapy Year: 2019 Personal strategies to minimise effects of air pollution on respiratory health: advice for providers, patients and the public Source: Eur Respir J, 55 (6) 1902056; 10.1183/13993003.02056-2019 Year: 2020 Patients with underuse and overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhalation medication Source: International Congress 2017 – Inhalers and their use Year: 2017 Cons - governments should impose targets for healthcare professionals to switch their respiratory disease patients to inhalers with a low global warming potential Source: International Congress 2019 – Recent clinical advances in inhalation therapy Year: 2019 COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique? Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs Source: Eur Respir J 2012; 40: 1072-1074 Year: 2012 Is there a problem with inhaled corticosteroid use in COPD? Source: Virtual Congress 2020 – Airway diseases Year: 2020 Feedback on inhaler use does not significantly improve inhaled corticosteroid adherence or clinical outcomes Source: Virtual Congress 2020 – Digital technologies in airway diseases Year: 2020 Asthma-related resource use and costs for patients prescribed inhaled corticosteroids compared to leukotriene modifiers in clinical practice Source: Annual Congress 2010 - Management of airway disease Year: 2010 What are the key issues in the inhaler therapy in children? Source: Annual Congress 2004 - How can we improve asthma management? Year: 2004 Optimal adherence with inhaled corticosteroids is related to better health status Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 How can we improve patient use of inhaler devices in COPD? Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 Asthma and once-daily administration of inhaled corticosteroids: potential for improved compliance and reduced health costs Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002